LivaNova PLC
LIVNNASDAQHealthcareMedical - Devices
Previous close
$78.74
+$0.53 · +0.68%
Pre-market
$79.6612
+$0.9212 · +1.17%
Aug 24, 4:27 AM ET
LIVN company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Buy
Favorable setup — positive multi-factor alignment
Valuation
78
Undervalued
Momentum
64
Gaining
Sentiment
65
Bullish
Risk resilience
80
Low Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteLivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- GB
- CEO
- Vladimir A. Makatsaria
- Listed since
- Oct 19, 2015
- Employees
- 3,300
Market position
Day range
Current $78.74
52-week range
Current $78.74
- Open
- $78.36
- Previous close
- $78.21
- Volume
- 440.22K
- 0.58× average
- Average volume
- 755.7K
- Average daily volume
- Market cap
- 4.33B USD
- Beta
- 0.87
- Market reference 1
- 50-day average
- $80.4931
- -2.18% below average
- 200-day average
- $68.4153
- +15.09% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 3.19B USD
- EV / EBITDA
- -24.64×
- Earnings yield
- -7.23%
- Free cash flow yield
- 5.16%
Profitability & efficiency
- Return on equity
- -20.21%
- Return on assets
- -9.31%
- Return on invested capital
- 10.90%
Financial health
- Current ratio
- 1.36×
- Altman Z-score
- 2.33
- Piotroski F-score
- 8 of 9
Earnings
- EPS beat rate
- 100%
- 11 beats, 0 misses, 0 met estimates
- Average EPS surprise
- +19.96%
- 11 comparable reports
- Latest EPS result
- 1.26
- Estimate 1.09 · Beat by 15.60%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$88.20
12.01% upsideLIVN peers
ETFs holding LIVN
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Mid-Cap ETFIJH154.73M0.12%125.92B USD0.05%$76.77+0.52%
Avantis U.S. Small Cap Value ETFAVUV126.05M0.41%31.27B USD0.25%$126.45+0.66%
iShares Russell 2000 ETFIWM111.69M0.14%81.62B USD0.19%$299.96+0.77%
Vanguard Extended Market ETFVXF50.64M0.05%93.7B USD0.05%$245.53+0.82%
iShares Russell 2000 Value ETFIWN32.35M0.22%14.66B USD0.24%$224.81+0.45%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY31.46M0.12%26.72B USD0.23%$699.6+0.48%
Invesco S&P MidCap Quality ETFXMHQ29.26M0.52%5.67B USD0.31%$119.27+0.45%
iShares S&P Mid-Cap 400 Growth ETFIJK26.15M0.23%10.95B USD0.16%$115.45+0.37%iShares Core S&P Mid-Cap ETFIJH- Market value
- 154.73M
- Weight
- 0.12%
- AUM
- 125.92B USD
- Expense ratio
- 0.05%
- Price / 1D
- $76.77+0.52%
Avantis U.S. Small Cap Value ETFAVUV- Market value
- 126.05M
- Weight
- 0.41%
- AUM
- 31.27B USD
- Expense ratio
- 0.25%
- Price / 1D
- $126.45+0.66%
iShares Russell 2000 ETFIWM- Market value
- 111.69M
- Weight
- 0.14%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Extended Market ETFVXF- Market value
- 50.64M
- Weight
- 0.05%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Russell 2000 Value ETFIWN- Market value
- 32.35M
- Weight
- 0.22%
- AUM
- 14.66B USD
- Expense ratio
- 0.24%
- Price / 1D
- $224.81+0.45%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY- Market value
- 31.46M
- Weight
- 0.12%
- AUM
- 26.72B USD
- Expense ratio
- 0.23%
- Price / 1D
- $699.6+0.48%
Invesco S&P MidCap Quality ETFXMHQ- Market value
- 29.26M
- Weight
- 0.52%
- AUM
- 5.67B USD
- Expense ratio
- 0.31%
- Price / 1D
- $119.27+0.45%
iShares S&P Mid-Cap 400 Growth ETFIJK- Market value
- 26.15M
- Weight
- 0.23%
- AUM
- 10.95B USD
- Expense ratio
- 0.16%
- Price / 1D
- $115.45+0.37%
Continue in GoAI
Research LIVNresearch.disclaimer